Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy

AIMS: Peripartum cardiomyopathy (PPCM) is a systolic left ventricular dysfunction developing in the peripartum phase in previously healthy women. Relaxin-2 is a pregnancy hormone with potential beneficial effects in heart failure patients. We evaluated Relaxin-2 as a potential diagnostic marker and/...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Res
Autores principales: Nonhoff, Justus, Ricke-Hoch, Melanie, Mueller, Mirco, Stapel, Britta, Pfeffer, Tobias, Kasten, Martina, Scherr, Michaela, von Kaisenberg, Constantin, Bauersachs, Johann, Haghikia, Arash, Hilfiker-Kleiner, Denise
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412020/
https://ncbi.nlm.nih.gov/pubmed/28453725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvw245
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares